国际肿瘤学杂志

国际肿瘤学杂志 ›› 2012, Vol. 39 ›› Issue (3): 182-186.

• 综述 • 上一篇    下一篇

EZH2与肿瘤的关系

白洁, 帅晓明, 陶凯雄   

  1. 430022武汉，华中科技大学同济医学院附属协和医院胃肠外科
  • 出版日期:2012-03-08 发布日期:2012-02-24

EZH2 gene and cancer

BAI  Jie, SHUAI  Xiao-Ming, TAO  Kai-Xiong   

  1. Department of Gastrointestinal Surgery, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
  • Online:2012-03-08 Published:2012-02-24

PDF

3254

被引次数

3

摘要： EZH2是PRC2的一个亚基，通过催化组蛋白H3第27位赖氨酸三甲基化抑制基因表达。在前列腺癌、乳腺癌、膀胱癌及胃癌等多种肿瘤中都有高表达，与肿瘤的恶性进程、侵袭性、转移能力关系密切。随着对其在肿瘤中分子功能、上下游调控机制、临床病理特点的深入了解，EZH2有望做为靶点，为肿瘤治疗提供新的途径。

关键词: color: green, font-family: 宋体, mso-ansi-language: EN-US, mso-fareast-language: ZH-CN, mso-bidi-language: AR-SA, mso-bidi-font-family: 宋体, mso-font-kerning: 1.0pt">肿瘤, 治疗, EZH2

Abstract: EZH2 is the catalytic subunit of polycomb repressive complex 2 (PRC2), which represses gene expression by catalyzing lysine 27 of histone H3. It is overexpressed in prostate cancer, breast cancer, bladder cancer, gastric cancer and several other cancers.There is a close correlation between overexpression of EZH2 and progression of malignancy, invasion and migration of cancer cells. With a thorough understanding of the function, up and down stream regulatory mechanism and clinicopathological features, EZH2 will be expected to as a target and provide a new way for the treatment of cancers.

Key words: color: green, font-family: "Times New Roman", mso-ansi-language: EN-US, mso-fareast-language: ZH-CN, mso-bidi-language: AR-SA, mso-fareast-font-family: 宋体">Neoplasms, color: green, font-family: "Times New Roman", mso-ansi-language: EN-US, mso-fareast-language: ZH-CN, mso-bidi-language: AR-SA, mso-fareast-font-family: 宋体, mso-font-kerning: 1.0pt">Therapy, color: green, font-family: "Times New Roman", mso-ansi-language: EN-US, mso-fareast-language: ZH-CN, mso-bidi-language: AR-SA, mso-fareast-font-family: 宋体, mso-font-kerning: 1.0pt">EZH2